- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Indian American doctor, wife to pay 1.2 mn dollar for prescribing unapproved drugs
New York: A prominent Indian-American doctor and his wife have agreed to pay USD 1.2 million to settle allegations of prescribing unapproved drugs in the US.
The couple allegedly profited by administering the cheaper unapproved drugs, the Department of Justice said.
They will pay USD 1.2 million to resolve state and federal False Claims Act allegations that their medical practice billed Medicare and Tennessee Medicaid for anti- cancer and infusion drugs that were produced for sale in foreign countries and not approved by the Food and Drug Administration (FDA) for marketing in the US, it said.
"Billing for foreign drugs that are not approved by the FDA undermines federal healthcare programmes and could potentially risk patient safety," said Acting Assistant Attorney General Chad Readler of the Justice Departments Civil Division.
The government alleged that the unapproved drugs that the Sens provided to patients and billed to Medicare were not reimbursable under those programmes.
It is further alleged that the Sens purchased unapproved drugs because they were less expensive than the drugs approved by FDA for marketing in the US.
Claims settled by this agreement are allegations only and there has been no determination of liability, the Justice Department added.